RJ

Active Director Director DIN 00332275
DIN 00332275 First appointment Apr 1996 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 1996
Shareholding value •••• Premium profile

About Rosy Jain

Data last updated:

Rosy Jain is a Director at Carewell Biotech Private Limited (since 1996). The company operates in Healthcare. Carewell Biotech Private Limited reported revenue of ₹3.86 Cr (FY 2025).

DIN 00332275
Primary Designation Director
Industry Healthcare
First Appointment 01 Apr 1996
Oldest Company Age 31 yrs
Largest company Carewell Biotech Private Limited · ₹3.86 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Carewell Biotech Private Limited U74899DL1994PTC063026
Director01 Apr 19961994₹3.86 Cr (FY 2025)Active

Board colleagues of Rosy Jain

NameDINCompanyDesignation
Rakesh Kumar Jain00222410Carewell Biotech Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Carewell Biotech Private Limited
Premium access

Shareholding and investment profile for Rosy Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rosy Jain

Rosy Jain currently holds 1 directorship: Carewell Biotech Private Limited (Director, since 01 Apr 1996, revenue ₹3.86 Cr (FY 2025)).

Rosy Jain was first appointed on 01 Apr 1996 as Director at Carewell Biotech Private Limited.

The current boards of Rosy Jain's companies include Rakesh Kumar Jain (Carewell Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available